title: Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors.
abstract: Chemical genetics is a new field of study that employs diverse small-molecule compounds to interrogate specific biological functions. The chemical genetics approach has been recently applied to microglial biology. Microglial cells are the primary immune cells of the brain, and are believed to play a major role in both host defense and tissue repair in the central nervous system. However, excessive microglial activation with overexpression of proinflammatory cytokines and oxidative stress products is linked to the progression of several neurodegenerative diseases. Therefore, suppression of microglial activation and subsequent neuroinflammation may be a potential therapeutic approach against these diseases. From microglia cell-based assays, the natural compound obovatol and several synthetic compounds were identified as inhibitors of microglial activation. They showed strong anti-neuroinflammatory activities in various in vitro and in vivo studies. Nuclear factor-κB and mitogen-activated protein kinase pathways were found to be related to the effects of these compounds on microglia. In particular, based on the affinity purification approach, peroxiredoxin 2 was identified as a microglial target of obovatol. Thus, natural and synthetic compounds are not only important biological tools for the study of microglial physiology and pathology, but they are also attractive candidates for the development of therapeutic drugs against neuroinflammatory and neurodegenerative diseases.
authors.affiliation: Department of Pharmacology, Brain Science and Engineering Institute, CMRI, Kyungpook National University School of Medicine, 680 Gukchaebosang Street, Joong-gu, Daegu 700-422, Korea. ksuk@knu.ac.kr
authors.forename: Kyoungho
authors.initials: K
authors.lastname: Suk
authors.forename: Jiyeon
authors.initials: J
authors.lastname: Ock
mesh_terms: D000818:Animals; D001713:Biphenyl Compounds / Q000008:administration & dosage / Q000737:chemistry; D002626:Chemistry, Pharmaceutical / Q000379:methods / Q000639:trends*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000737:chemistry; D007249:Inflammation / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D017628:Microglia / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000737:chemistry*; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000737:chemistry; D011725:Pyridines / Q000008:administration & dosage / Q000737:chemistry
chemical_list: D001713:Biphenyl Compounds; D007093:Imidazoles; C546458:KR 31360; D018696:Neuroprotective Agents; D010647:Phenyl Ethers; D011725:Pyridines; C036795:obovatol